After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...